Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut

Abstract

Breastfeeding profoundly shapes the infant gut microbiota, which is critical for early life immune development, and the gut microbiota can impact host physiology in various ways, such as through the production of metabolites. However, few breastmilk-dependent microbial metabolites mediating host–microbiota interactions are currently known. Here, we demonstrate that breastmilk-promoted Bifidobacterium species convert aromatic amino acids (tryptophan, phenylalanine and tyrosine) into their respective aromatic lactic acids (indolelactic acid, phenyllactic acid and 4-hydroxyphenyllactic acid) via a previously unrecognized aromatic lactate dehydrogenase (ALDH). The ability of Bifidobacterium species to convert aromatic amino acids to their lactic acid derivatives was confirmed using monocolonized mice. Longitudinal profiling of the faecal microbiota composition and metabolome of Danish infants ( n = 25), from birth until 6 months of age, showed that faecal concentrations of aromatic lactic acids are correlated positively with the abundance of human milk oligosaccharide-degrading Bifidobacterium species containing the ALDH, including Bifidobacterium longum , B. breve and B. bifidum . We further demonstrate that faecal concentrations of Bifidobacterium -derived indolelactic acid are associated with the capacity of these samples to activate in vitro the aryl hydrocarbon receptor (AhR), a receptor important for controlling intestinal homoeostasis and immune responses. Finally, we show that indolelactic acid modulates ex vivo immune responses of human CD4 + T cells and monocytes in a dose-dependent manner by acting as an agonist of both the AhR and hydroxycarboxylic acid receptor 3 (HCA 3 ). Our findings reveal that breastmilk-promoted Bifidobacterium species produce aromatic lactic acids in the gut of infants and suggest that these microbial metabolites may impact immune function in early life.

References 111

1. 1.

   Victora CG, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387:475-490.

   Not in our library10.1016/s0140-6736(15)01024-7

2. 2.

   Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015;104:30-37.

   Not in our library10.1111/apa.13133

3. 3.

   Oddy WH. Breastfeeding, childhood asthma, and allergic disease. Ann. Nutr. Metab. 2017;70:26-36.

   Not in our library10.1159/000457920

4. 4.
   Infant Gut Microbiota Development Is Driven by Transition to Family Foods Independent of Maternal Obesity · 2016

   No notice
5. 5.

   Bäckhed F, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690-703.

   Not in our library10.1016/j.chom.2015.04.004

6. 6.
   Temporal development of the gut microbiome in early childhood from the TEDDY study · 2018

   No notice
7. 7.

   Bode L. The functional biology of human milk oligosaccharides. Early Hum. Dev. 2015;91:619-622.

   Not in our library10.1016/j.earlhumdev.2015.09.001

8. 8.

   Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539-544.

   Not in our library10.1126/science.aad9378

9. 9.
   Maturation of the gut microbiome and risk of asthma in childhood · 2018

   Corrected
10. 10.

    Fujimura KE, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 2016;22:1187-1191.

    Not in our library10.1038/nm.4176

11. 11.

    Khosravi A, Mazmanian SK. Disruption of the gut microbiome as a risk factor for microbial infections. Curr. Opin. Microbiol. 2013;16:221-227.

    Not in our library10.1016/j.mib.2013.03.009

12. 12.

    Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543-547.

    Not in our library10.1038/nature09646

13. 13.
    The human gut microbiome in early-onset type 1 diabetes from the TEDDY study · 2018

    No notice
14. 14.
    Microbial tryptophan catabolites in health and disease · 2018

    No notice
15. 15.

    Zelante T, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372-385.

    Not in our library10.1016/j.immuni.2013.08.003

16. 16.

    Cervantes-Barragan, L. et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells. Science10.1126/science.aah5825 (2017).

    Not in our library10.1126/science.aah5825

17. 17.

    Natividad, J. M. et al. Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab. 10.1016/j.cmet.2018.07.001 (2018).

    Not in our library10.1016/j.cmet.2018.07.001

18. 18.

    Dodd D, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648-652.

    Not in our library10.1038/nature24661

19. 19.

    Guo X, et al. Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity. 2015;42:731-743.

    Not in our library10.1016/j.immuni.2015.03.012

20. 20.

    Hoyles L, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat. Med. 2018;24:1070-1080.

    Not in our library10.1038/s41591-018-0061-3

21. 21.

    Krishnan S, et al. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 2018;23:1099-1111.

    Not in our library10.1016/j.celrep.2018.03.109

22. 22.

    Madsen AL, Schack-Nielsen L, Larnkjaer A, Mølgaard C, Michaelsen KF. Determinants of blood glucose and insulin in healthy 9-month-old term Danish infants; the SKOT cohort. Diabet. Med. 2010;27:1350-1357.

    Not in our library10.1111/j.1464-5491.2010.03134.x

23. 23.
    Age-Related Changes in the Composition of Gut Bifidobacterium Species · 2017

    No notice
24. 24.

    Koga Y, et al. Age-associated effect of kestose on Faecalibacterium prausnitzii and symptoms in the atopic dermatitis infants. Pediatr. Res. 2016;80:844-851.

    Not in our library10.1038/pr.2016.167

25. 25.

    Li X, Jiang B, Pan B, Mu W, Zhang T. Purification and partial characterization of Lactobacillus species SK007 lactate dehydrogenase (LDH) catalyzing phenylpyruvic acid (PPA) conversion into phenyllactic acid (PLA). J. Agric. Food Chem. 2008;56:2392-2399.

    Not in our library10.1021/jf0731503

26. 26.

    Koide S, Iwata S, Matsuzawa H, Ohta T. Crystallization of allosteric l-lactate dehydrogenase from Thermus caldophilus and preliminary crystallographic data. J. Biochem. 1991;109:6-7.

    Not in our library

27. 27.

    Takashi M, So I, Hiroshi S, Haruhiko M, Takahisa O. Sequence and characteristics of the Bifidobacterium longum gene encoding l-lactate dehydrogenase and the primary structure of the enzyme: a new feature of the allosteric site. Gene. 1989;85:161-168.

    Not in our library10.1016/0378-1119(89)90476-9

28. 28.

    Bottacini F, et al. Global transcriptional landscape and promoter mapping of the gut commensal Bifidobacterium breve UCC2003. BMC Genomics. 2017;18:991.

    Not in our library10.1186/s12864-017-4387-x

29. 29.

    Hirayama Y, et al. Development of a double-crossover markerless gene deletion system in Bifidobacterium longum: functional analysis of the α-galactosidase gene for raffinose assimilation. Appl. Environ. Microbiol. 2012;78:4984-4994.

    Not in our library10.1128/aem.00588-12

30. 30.

    Matsumura H, Takeuchi A, Kano Y. Construction of Escherichia coli–Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A. Biosci. Biotechnol. Biochem. 1997;61:1211-1212.

    Not in our library10.1271/bbb.61.1211

31. 31.
    Multivariable association discovery in population-scale meta-omics studies · 2021

    No notice
32. 32.
    Repeated Measures Correlation · 2017

    Corrected
33. 33.

    Alfa MJ, et al. An outbreak of necrotizing enterocolitis associated with a novel Clostridium species in a neonatal intensive care unit. Clin. Infect. Dis. 2002;35:S101-S105.

    Not in our library10.1086/341929

34. 34.

    Butel M-J, et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J. Pediatr. Gastroenterol. Nutr. 2007;44:577-582.

    Not in our library10.1097/mpg.0b013e3180406b20

35. 35.
    Bacterial Diversity in Meconium of Preterm Neonates and Evolution of Their Fecal Microbiota during the First Month of Life · 2013

    No notice
36. 36.

    Arboleya S, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol. Ecol. 2012;79:763-772.

    Not in our library10.1111/j.1574-6941.2011.01261.x

37. 37.
    Intestinal microbiota development and gestational age in preterm neonates · 2018

    No notice
38. 38.
    Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3 · 2019

    Corrected
39. 39.

    Ahmed K, et al. Deorphanization of GPR109B as a receptor for the β-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J. Biol. Chem. 2009;284:21928-21933.

    Not in our library10.1074/jbc.m109.019455

40. 40.

    Irukayama-Tomobe Y, et al. Aromatic d-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B. Proc. Natl Acad. Sci. USA. 2009;106:3930-3934.

    Not in our library10.1073/pnas.0811844106

41. 41.
    Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles · 2015

    No notice
42. 42.

    Quintana FJ, et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453:65-71.

    Not in our library10.1038/nature06880

43. 43.

    Veldhoen M, Hirota K, Christensen J, O’Garra A, Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 2009;206:43-49.

    Not in our library10.1084/jem.20081438

44. 44.

    Veldhoen M, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453:106-109.

    Not in our library10.1038/nature06881

45. 45.

    Komura K, Hayashi SI, Makino I, Poellinger L, Tanaka H. Aryl hydrocarbon receptor/dioxin receptor in human monocytes and macrophages. Mol. Cell. Biochem. 2001;226:107-117.

    Not in our library10.1023/a:1012762519424

46. 46.

    Offermanns S. Hydroxy-carboxylic acid receptor actions in metabolism. Trends Endocrinol. Metab. 2017;28:227-236.

    Not in our library10.1016/j.tem.2016.11.007

47. 47.

    Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat. Med. 2016;22:713-722.

    Not in our library10.1038/nm.4142

48. 48.

    Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut. 2019;68:1108-1114.

    Not in our library10.1136/gutjnl-2018-317503

49. 49.

    Yamada C, et al. Molecular insight into evolution of symbiosis between breast-fed infants and a member of the human gut microbiome Bifidobacterium longum. Cell Chem. Biol. 2017;24:515-524.

    Not in our library10.1016/j.chembiol.2017.03.012

50. 50.

    Katayama T. Host-derived glycans serve as selected nutrients for the gut microbe: human milk oligosaccharides and bifidobacteria. Biosci. Biotechnol. Biochem. 2016;80:621-632.

    Not in our library10.1080/09168451.2015.1132153

51. 51.

    Thomson P, Medina DA, Garrido D. Human milk oligosaccharides and infant gut bifidobacteria: molecular strategies for their utilization. Food Microbiol. 2018;75:37-46.

    Not in our library10.1016/j.fm.2017.09.001

52. 52.

    Sakanaka M, et al. Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria–infant symbiosis. Sci. Adv. 2019;5:eaaw7696.

    Not in our library10.1126/sciadv.aaw7696

53. 53.

    Sakurai T, Odamaki T, Xiao J-Z. Production of indole-3-lactic acid by bifidobacterium strains isolated from human infants. Microorganisms. 2019;7:340.

    Not in our library10.3390/microorganisms7090340

54. 54.

    Meng D, et al. Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine. Pediatr. Res. 2020;88:209-217.

    Not in our library10.1038/s41390-019-0740-x

55. 55.
    Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells · 2020

    No notice
56. 56.

    Neil JA, et al. IFN-I and IL-22 mediate protective effects of intestinal viral infection. Nat. Microbiol. 2019;4:1737-1749.

    Not in our library10.1038/s41564-019-0470-1

57. 57.
    IL-22 Mediates Goblet Cell Hyperplasia and Worm Expulsion in Intestinal Helminth Infection · 2013

    No notice
58. 58.

    Zheng Y, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008;14:282-289.

    Not in our library10.1038/nm1720

59. 59.

    Sugimoto K, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 2008;118:534-544.

    Not in our library10.1172/jci33194

60. 60.

    Keir ME, Yi T, Lu TT, Ghilardi N. The role of IL-22 in intestinal health and disease. J. Exp. Med. 2020;217:e20192195.

    Not in our library10.1084/jem.20192195

61. 61.

    Natividad JM, et al. Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab. 2018;28:737-749.

    Not in our library10.1016/j.cmet.2018.07.001

62. 62.
    The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity · 2018

    Corrected
63. 63.

    Gomez de Aguero M, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351:1296-1302.

    Not in our library10.1126/science.aad2571

64. 64.

    Kiss EA, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science. 2011;334:1561-1565.

    Not in our library10.1126/science.1214914

65. 65.

    Qiu J, et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity. 2012;36:92-104.

    Not in our library10.1016/j.immuni.2011.11.011

66. 66.

    Lamas B, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 2016;22:598-605.

    Not in our library10.1038/nm.4102

67. 67.

    Dant TA, et al. T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD. Blood. 2017;130:348-359.

    Not in our library10.1182/blood-2016-08-734244

68. 68.

    Wilck N, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 2017;551:585-589.

    Not in our library10.1038/nature24628

69. 69.

    Quintana FJ, et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453:65-71.

    Not in our library10.1038/nature06880

70. 70.

    Ning Y, et al. Antibacterial activity of phenyllactic acid against Listeria monocytogenes and Escherichia coli by dual mechanisms. Food Chem. 2017;228:533-540.

    Not in our library10.1016/j.foodchem.2017.01.112

71. 71.

    Rodríguez N, Salgado JM, Cortés S, Domínguez JM. Antimicrobial activity of d-3-phenyllactic acid produced by fed-batch process against Salmonella enterica. Food Control. 2012;25:274-284.

    Not in our library10.1016/j.foodcont.2011.10.042

72. 72.

    Narayanan TK, Rao GR. Beta-indoleethanol and beta-indolelactic acid production by Candida species: their antibacterial and autoantibiotic action. Antimicrob. Agents Chemother. 1976;9:375-380.

    Not in our library10.1128/aac.9.3.375

73. 73.

    Honoré AH, et al. Metabolic footprinting for investigation of antifungal properties of Lactobacillus paracasei. Anal. Bioanal. Chem. 2016;408:83-96.

    Not in our library10.1007/s00216-015-9103-6

74. 74.

    Madsen AL, Larnkjær A, Mølgaard C, Michaelsen KF. IGF-I and IGFBP-3 in healthy 9 month old infants from the SKOT cohort: breastfeeding, diet, and later obesity. Growth Horm. IGF Res. 2011;21:199-204.

    Not in our library10.1016/j.ghir.2011.05.003

75. 75.

    Laursen MF, et al. Having older siblings is associated with gut microbiota development during early childhood. BMC Microbiol. 2015;15:154.

    Not in our library10.1186/s12866-015-0477-6

76. 76.

    Laursen, M. F., Dalgaard, M. D. & Bahl, M. I. Genomic GC-content affects the accuracy of 16S rRNA gene sequencing based microbial profiling due to PCR bias. Front. Microbiol.10.3389/fmicb.2017.01934 (2017).

    Not in our library10.3389/fmicb.2017.01934

77. 77.

    Laursen MF, et al. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. BMC Microbiol. 2017;17:175.

    Not in our library10.1186/s12866-017-1090-7

78. 78.

    Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods. 2013;10:996-998.

    Not in our library10.1038/nmeth.2604

79. 79.

    Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010;7:335-336.

    Not in our library10.1038/nmeth.f.303

80. 80.

    Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007;73:5261-5267.

    Not in our library10.1128/aem.00062-07

81. 81.

    DeSantis TZ, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006;72:5069-5072.

    Not in our library10.1128/aem.03006-05

82. 82.

    Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 1990;215:403-410.

    Not in our library10.1016/s0022-2836(05)80360-2

83. 83.

    Callahan BJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods. 2016;13:581-583.

    Not in our library10.1038/nmeth.3869

84. 84.
    Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants · 2017

    No notice
85. 85.

    Lawley B, et al. Differentiation of Bifidobacterium longum subspecies longum and infantis by quantitative PCR using functional gene targets. PeerJ. 2017;5:e3375.

    Not in our library10.7717/peerj.3375

86. 86.
    Longitudinal change of selected human milk oligosaccharides and association to infants’ growth, an observatory, single center, longitudinal cohort study · 2017

    No notice
87. 87.

    Xu G, et al. Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation. J. Nutr. 2017;147:117-124.

    Not in our library10.3945/jn.116.238279

88. 88.
    New insights from uncultivated genomes of the global human gut microbiome · 2019

    No notice
89. 89.

    Sakurama H, et al. Lacto-N-biosidase encoded by a novel gene of Bifidobacterium longum subspecies longum shows unique substrate specificity and requires a designated chaperone for its active expression. J. Biol. Chem. 2013;288:25194-25206.

    Not in our library10.1074/jbc.m113.484733

90. 90.

    Kanesaki Y, et al. Complete genome sequence of Bifidobacterium longum 105-A, a strain with high transformation efficiency. Genome Announc. 2014;2:e01311-14.

    Not in our library10.1128/genomea.01311-14

91. 91.

    Sakanaka M, et al. Functional analysis of bifidobacterial promoters in Bifidobacterium longum and Escherichia coli using the α-galactosidase gene as a reporter. J. Biosci. Bioeng. 2014;118:489-495.

    Not in our library10.1016/j.jbiosc.2014.05.002

92. 92.

    Poolman B, Nijssen RMJ, Konings WN. Dependence of Streptococcus lactis phosphate transport on internal phosphate concentration and internal pH. J. Bacteriol. 1987;169:5373-5378.

    Not in our library10.1128/jb.169.12.5373-5378.1987

93. 93.

    Barri T, Holmer-Jensen J, Hermansen K, Dragsted LO. Metabolic fingerprinting of high-fat plasma samples processed by centrifugation- and filtration-based protein precipitation delineates significant differences in metabolite information coverage. Anal. Chim. Acta. 2012;718:47-57.

    Not in our library10.1016/j.aca.2011.12.065

94. 94.

    Nielsen LN, et al. Glyphosate has limited short-term effects on commensal bacterial community composition in the gut environment due to sufficient aromatic amino acid levels. Environ. Pollut. 2018;233:364-376.

    Not in our library10.1016/j.envpol.2017.10.016

95. 95.

    Roager HM, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat. Microbiol. 2016;1:16093.

    Not in our library10.1038/nmicrobiol.2016.93

96. 96.

    Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006;78:779-787.

    Not in our library10.1021/ac051437y

97. 97.

    Sumner LW, et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2007;3:211-221.

    Not in our library10.1007/s11306-007-0082-2

98. 98.

    Gürdeniz G, Kristensen M, Skov T, Dragsted LO. The effect of LC-MS data preprocessing methods on the selection of plasma biomarkers in fed vs. fasted rats. Metabolites. 2012;2:77-99.

    Not in our library10.3390/metabo2010077

99. 99.
    MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data · 2010

    No notice
100. 100.

     van der Kloet FM, Bobeldijk I, Verheij ER, Jellema RH. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J. Proteome Res. 2009;8:5132-5141.

     Not in our library10.1021/pr900499r

101. 101.

     Smart KF, Aggio RBM, Van Houtte JR, Villas-Bôas SG. Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography–mass spectrometry. Nat. Protoc. 2010;5:1709-1729.

     Not in our library10.1038/nprot.2010.108

102. 102.

     Johnsen LG, Skou PB, Khakimov B, Bro R. Gas chromatography—mass spectrometry data processing made easy. J. Chromatogr. A. 2017;1503:57-64.

     Not in our library10.1016/j.chroma.2017.04.052

103. 103.

     Rosenmai AK, et al. Are structural analogues to bisphenol a safe alternatives? Toxicol. Sci. 2014;139:35-47.

     Not in our library10.1093/toxsci/kfu030

104. 104.

     Thysen AH, et al. Distinct immune phenotypes in infants developing asthma during childhood. Sci. Transl. Med. 2020;12:258.

     Not in our library10.1126/scitranslmed.aaw0258

105. 105.

     R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2013).

     Not in our library

106. 106.

     Wickhamm, H. ggplot2 Elegant Graphics for Data Analysis (Springer, 2009).

     Not in our library

107. 107.

     Vu, V. ggbiplot: a ggplot2 based biplot R v0.55 (2011).

     Not in our library

108. 108.

     Warnes, G. R. et al. gplots: various R programming tools for plotting data. R package v2.16.0 (2015).

     Not in our library

109. 109.

     Benjamini Y, Hochberg Y. Controlling the False Discovery Rate—a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 1995;57:289-300.

     Not in our library

110. 110.

     Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol. 1996;81:288-302.

     Not in our library10.1111/j.1365-2672.1996.tb04331.x

111. 111.

     Smith EA, Macfarlane GT. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb. Ecol. 1997;33:180-188.

     Not in our library10.1007/s002489900020

Cited by papers we hold 8

• Lactiplantibacillus plantarum attenuate gossypol-induced hepatic lipotoxicity by altering intestinal microbiota for enriching microbial tryptophan metabolites in Nile tilapia (Oreochromis niloticus) · 2025
  Not checked
• The microbiome in graft-versus-host disease: a tale of two ecosystems · 2025
  Not checked
• Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota · 2024
  No notice
• Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding · 2024
  No notice
• The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective · 2023
  No notice
• Bifidobacterium mechanisms of immune modulation and tolerance · 2023
  No notice
• Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial · 2022
  Not checked
• Microbiome-based interventions to modulate gut ecology and the immune system · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.